Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
53.1M
-
Number of holders
-
103
-
Total 13F shares, excl. options
-
36.3M
-
Shares change
-
+1.78M
-
Total reported value, excl. options
-
$780M
-
Value change
-
-$55.9M
-
Put/Call ratio
-
1.97
-
Number of buys
-
63
-
Number of sells
-
-58
-
Price
-
$21.49
Significant Holders of ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share (ALXO) as of Q4 2021
144 filings reported holding ALXO - ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share as of Q4 2021.
ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share (ALXO) has 103 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 36.3M shares
of 53.1M outstanding shares and own 68.3% of the company stock.
Largest 10 shareholders include venBio Partners LLC (9.7M shares), Vivo Capital, LLC (4.22M shares), WELLINGTON MANAGEMENT GROUP LLP (3.73M shares), Logos Global Management LP (2.91M shares), FMR LLC (2.59M shares), VANGUARD GROUP INC (1.71M shares), STATE STREET CORP (1.44M shares), BlackRock Inc. (1.34M shares), JANUS HENDERSON GROUP PLC (919K shares), and Redmile Group, LLC (782K shares).
This table shows the top 103 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.